The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis

Yucel, Nese; Baskent, Erdem; Balci, Burcin; Goynumer, Gokhan

doi:10.1111/ajo.12773

The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis

Atıf İçin Kopyala

Yucel N., Baskent E., Balci B. K. , Goynumer G.

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, cilt.58, ss.560-563, 2018 (SCI İndekslerine Giren Dergi)

Cilt numarası: 58 Konu: 5
Basım Tarihi: 2018
Doi Numarası: 10.1111/ajo.12773
Dergi Adı: AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
Sayfa Sayıları: ss.560-563

Özet

Background and aimsThe aim of this study was to investigate the effectiveness of a levonorgestrel-releasing intrauterine device (LNG-IUS) in the symptomatic relief of pain in women with endometriosis and additionally, to assess the changes in women's life quality and serum cancer antigen (CA) 125 levels.